Baidu
map

Int J Impot Res: 血清胎球蛋白A的水平可以作为勃起功能障碍的一个有用的标记

2017-04-28 AlexYang MedSci原创

最近,有研究人员在埃及人群中,就血清胎球蛋白A的水平与勃起功能障碍(ED)的表现和严重度的关系进行了评估。研究人员将60名ED患者和20名年龄匹配的健康人作为对照来进行试验,并进行了所有参与者全面的医疗历史信息的获得和全方位的身体检查。研究人员利用国际勃起功能指数(IIEF-5)来对ED和其严重度进行评估,并对多普勒超声、空腹血糖水平、血脂、血清睾丸素(TT)水平和血清胎球蛋白水平进行了检测。研究

最近,有研究人员在埃及人群中,就血清胎球蛋白A的水平与勃起功能障碍(ED)的表现和严重度的关系进行了评估。研究人员将60名ED患者和20名年龄匹配的健康人作为对照来进行试验,并进行了所有参与者全面的医疗历史信息的获得和全方位的身体检查。研究人员利用国际勃起功能指数(IIEF-5)来对ED和其严重度进行评估,并对多普勒超声、空腹血糖水平、血脂、血清睾丸素(TT)水平和血清胎球蛋白水平进行了检测。

研究结果发现,在ED组和健康对照组中,身体健康指数、牛血清、胆固醇、低密度脂蛋白、高密度脂蛋白和甘油三酯都没有统计学上的差异。但是,研究发现,IIEF-5和血清睾丸素的水平在ED组中显著降低。另外,胎球蛋白A在ED病人中的水平也显著降低。除此之外,严重ED患者比中度ED患者和轻度ED患者的血清胎球蛋白A水平更低。血清胎球蛋白A的水平跟胆固醇、低密度脂蛋白、甘油三酯和勃起功能指数-5呈正相关,而与高密度脂蛋白呈负相关。最后,研究人员指出,血清胎球蛋白A水平可以成为ED诊断的一个潜在的有用的敏感生物标记。

原始出处:

W Kandeel, W El-Shaer, A Sebaey et al. Usefulness of serum fetuin-A level as a marker of erectile dysfunction. Int J Impot Res. 20 March 2017. doi:10.1038/ijir.2017.21

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771131, encodeId=95241e7113163, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Tue Jan 09 12:48:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035140, encodeId=260220351406c, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Mon Dec 11 15:48:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421075, encodeId=338214210e57b, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502711, encodeId=02021502e11cc, content=<a href='/topic/show?id=bf0f3342395' target=_blank style='color:#2F92EE;'>#勃起功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33423, encryptionId=bf0f3342395, topicName=勃起功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e529549448, createdName=liuyiping, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575061, encodeId=51a115e506108, content=<a href='/topic/show?id=6f66121e89e' target=_blank style='color:#2F92EE;'>#MPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12178, encryptionId=6f66121e89e, topicName=MPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9016060451, createdName=风铃826, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
    2018-01-09 habb
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771131, encodeId=95241e7113163, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Tue Jan 09 12:48:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035140, encodeId=260220351406c, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Mon Dec 11 15:48:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421075, encodeId=338214210e57b, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502711, encodeId=02021502e11cc, content=<a href='/topic/show?id=bf0f3342395' target=_blank style='color:#2F92EE;'>#勃起功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33423, encryptionId=bf0f3342395, topicName=勃起功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e529549448, createdName=liuyiping, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575061, encodeId=51a115e506108, content=<a href='/topic/show?id=6f66121e89e' target=_blank style='color:#2F92EE;'>#MPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12178, encryptionId=6f66121e89e, topicName=MPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9016060451, createdName=风铃826, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
    2017-12-11 xzw113
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771131, encodeId=95241e7113163, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Tue Jan 09 12:48:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035140, encodeId=260220351406c, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Mon Dec 11 15:48:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421075, encodeId=338214210e57b, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502711, encodeId=02021502e11cc, content=<a href='/topic/show?id=bf0f3342395' target=_blank style='color:#2F92EE;'>#勃起功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33423, encryptionId=bf0f3342395, topicName=勃起功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e529549448, createdName=liuyiping, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575061, encodeId=51a115e506108, content=<a href='/topic/show?id=6f66121e89e' target=_blank style='color:#2F92EE;'>#MPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12178, encryptionId=6f66121e89e, topicName=MPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9016060451, createdName=风铃826, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771131, encodeId=95241e7113163, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Tue Jan 09 12:48:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035140, encodeId=260220351406c, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Mon Dec 11 15:48:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421075, encodeId=338214210e57b, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502711, encodeId=02021502e11cc, content=<a href='/topic/show?id=bf0f3342395' target=_blank style='color:#2F92EE;'>#勃起功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33423, encryptionId=bf0f3342395, topicName=勃起功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e529549448, createdName=liuyiping, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575061, encodeId=51a115e506108, content=<a href='/topic/show?id=6f66121e89e' target=_blank style='color:#2F92EE;'>#MPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12178, encryptionId=6f66121e89e, topicName=MPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9016060451, createdName=风铃826, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1771131, encodeId=95241e7113163, content=<a href='/topic/show?id=c1c6334227d' target=_blank style='color:#2F92EE;'>#勃起#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33422, encryptionId=c1c6334227d, topicName=勃起)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78b838213583, createdName=habb, createdTime=Tue Jan 09 12:48:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035140, encodeId=260220351406c, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Mon Dec 11 15:48:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421075, encodeId=338214210e57b, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502711, encodeId=02021502e11cc, content=<a href='/topic/show?id=bf0f3342395' target=_blank style='color:#2F92EE;'>#勃起功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33423, encryptionId=bf0f3342395, topicName=勃起功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e529549448, createdName=liuyiping, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575061, encodeId=51a115e506108, content=<a href='/topic/show?id=6f66121e89e' target=_blank style='color:#2F92EE;'>#MPO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12178, encryptionId=6f66121e89e, topicName=MPO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9016060451, createdName=风铃826, createdTime=Sun Apr 30 14:48:00 CST 2017, time=2017-04-30, status=1, ipAttribution=)]
    2017-04-30 风铃826

相关资讯

J Sex Med:关于阴茎长短、粗细的测量

很多男性都想行阴茎增长增粗的治疗,对于他们的咨询最好的方法就是告诉他们什么是“正常”。尽管一些研究表明,迟缓无力状态下的拉伸长度和勃起时阴茎长度之间具有相关性,不过同时对迟缓状态下拉伸和勃起状态进行阴茎长度测量,该值变化却很大。研究者进行了一项研究,探究不同阴茎测量方法的精确性。该研究共纳入了201名成年男性,平均年龄49.6岁,通过阴茎注射可以达到完全勃起状态。随机由七名男科学专家中的一个对研究

Eur Urol:人类阴茎移植和排斥反应的间接体内疗法新模型:对勃起组织生理机能的影响

阴茎移植是一种治疗阴茎组织受到严重损失的潜在治疗选择方法。但是人类阴茎移植排斥模型还缺乏。研究人员利用一种新的间接体内疗法混合淋巴细胞反应模型来评估排斥反应和免疫抑制反应对海绵组织的影响。研究材料为10位经历过阴茎假体手术的病人的海绵组织和外周血单个核细胞以及1位健康志愿者的外周血单个核细胞。研究人员为该模型准备了三种培养基质,即单纯的基质、加有同源外周血单个核细胞的基质和加有异源外周血单个核细胞

J Clin Endocrinol Meta: 睾酮疗法有效地改善老年男性的性活动

近期有研究表明,对有症状的低睾酮水平的老年男性,使用持续睾酮治疗,能改善大多数类型的性活动。贝勒医学院和休斯敦贝勒圣路加医疗中心的Glenn R. Cunningham博士和他的同事评估了470名年龄在65岁或以上的性欲低下、平均睾酮275 ng/dL、有愿意一个月至少两次性交的伴侣的男性进行了此项睾酮试验。参与者被随机分配到的睾酮凝胶(AndroGel 1%, AbbVie; n = 234)

BMJ Case Rep:阴茎持续勃起36小时!

24岁男性,因“阴茎持续勃起伴疼痛36小时”就诊。患者尝试使用冰、运动、射精、消肿等方式,但小弟弟不听话,依旧挺拔。在过去的一年里,患者出现过6次阴茎异常勃起,最近一次发生在7天前。经过简单的“排水”治疗后,症状很快消失。患者是胰岛素依赖型1型糖尿病,从12岁就开始血糖的自我管理。此外患者是一个非常有活力的人,每天都进行剧烈运动。自17岁开始,患者间断性使用可卡因、大麻和同化激素。患者此次阴茎异常

JSM:致命蜘蛛毒素或改善男性勃起功能障碍

    科学家发现,巴西游走蛛分泌的毒素注入身体20分钟内,就能让勃起功能障碍者重振雄风。这种毒液可能是有效改善男性性生活质量的秘密武器。     通过老鼠进行的试验显示,巴西游走蛛毒液能够增加一氧化氮(可扩张血管,促进血流的一种化学物质)的分泌量,大大提高勃起功能。这与当前治疗阳痿的药物的起效原理类似。死于巴西游走蛛的人比死于其他蜘蛛

Baidu
map
Baidu
map
Baidu
map